NEOG - Neogen Corp - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
5/12/25 14:30	5/12/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Gupta Aashima	MI	D		P	100	6.25	16	270	22	D
4/25/25 16:32	4/25/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Woteki Catherine E	MI	D		P	30	5.17	6	77	13	D
4/25/25 14:45	4/24/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	MI	D		P	150	4.99	30	50	90	D
4/24/25 15:34	4/24/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T	MI	D		P	26	5.24	5	16	36	D
4/24/25 11:18	4/24/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	MI	D		P	171	4.89	35	137	60	D
4/23/25 10:46	4/23/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Rocklin Amy M	MI	O	GC	P	62	4.99	13	53	36	D
4/22/25 15:37	4/22/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Capello Jeffrey D	MI	D		P	100	4.84	21	350	27	D
4/22/25 11:46	4/22/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	47	4.73	10	36	37	D
4/22/25 11:43	4/22/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Rodriguez Rafael A	MI	D		P	34	4.59	7	100	15	D
4/10/25 10:12	4/10/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Moylan John Patrick	MI	O	Chief Ac	P	51	5.07	10	New	10	D
1/16/25 15:28	1/16/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Naemura David H.	MI	O	CFO	P	164	11.11	15	32	61	D
1/16/25 12:05	1/16/25	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	O	CEO	P	254	11.03	23	9	269	D
10/15/24 09:21	10/11/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	O	CEO	P	200	13.80	15	7	216	D
8/7/24 10:17	8/6/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	51	16.86	3	15	23	D
4/17/24 12:04	4/17/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	124	12.36	10	28	46	D
4/11/24 11:40	4/11/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	DE	D		P	98	13.06	8	54	21	D
4/10/24 16:18	4/10/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Naemura David H.	MI	O	CFO	P	156	12.51	13	71	30	D
4/10/24 14:25	4/10/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	O	CEO	P	284	12.36	23	18	152	D
11/3/23 13:59	11/3/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		P	32	16.06	2	8	27	D
10/26/23 08:01	10/25/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	152	15.17	10	38	36	D
10/12/23 16:01	10/12/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	46	15.19	3	17	20	D
10/11/23 16:21	10/11/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Naemura David H.	MI	O	CFO	P	150	15.03	10	New	10	D
1/18/23 17:04	1/13/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	45	17.91	3	27	12	D
10/11/22 19:09	10/11/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	58	11.63	5	18	33	D
10/4/22 18:43	10/3/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		P	28	13.89	2	9	23	D
9/28/22 17:29	9/28/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	100	14.31	7	254	10	D
9/28/22 17:27	9/28/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	CO	DO	P,CEO	P	316	14.37	22	38	80	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y